Journal of Controlled Release · 2018 · 46 citations · 48 references
PharmacyOncologyPharmacologyDrug DeliveryGynecologic OncologyTargeted Drug DeliveryCancer Drug DeliveryLiposomal FormulationsLiposome-based DeliveryNanocarriers For TherapeuticsOvarian CancerTargeted Cancer TherapyCyclodextrin-based NanocarriersHigh-grade Serous Ovarian CarcinomaLiposomal Co-deliveryLiposomal Delivery SystemsLiposomal NanocarriersOvarian Cancer TreatmentSerous Ovarian Tumors
48
Integrated genomic analyses of ovarian carcinoma
Debra Bell, Andrew Berchuck, Narciso Olvera et al. · Nature · 2011 · 8.2K citations · Full text
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text
Medicine, Oncology, Pharmacology +17
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text
Medicine, Gynecology, Oncology +11